STK4 INHIBITORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
The application relates to compounds of Formula (I'): which modulate the activity of a kinase (e.g., STK4), a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease or disorder associated with the modulation of a kinase, such as STK4.
-
(2017/01/09)
TYROSINE KINASE INHIBITORS
The present invention relates to pyridazin-4(1H)-one derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
-
Page/Page column 127; 128
(2011/08/03)
More Articles about upstream products of 1314390-00-5